View ValuationSPM 将来の成長Future 基準チェック /06現在、 SPMの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Pharmaceuticals 収益成長14.8%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • May 06SPM Corporation, Annual General Meeting, Jun 26, 2026SPM Corporation, Annual General Meeting, Jun 26, 2026.Reported Earnings • Apr 25First quarter 2026 earnings released: EPS: ₫234 (vs ₫229 in 1Q 2025)First quarter 2026 results: EPS: ₫234 (up from ₫229 in 1Q 2025). Revenue: ₫46.0b (down 44% from 1Q 2025). Net income: ₫3.22b (up 2.1% from 1Q 2025). Profit margin: 7.0% (up from 3.8% in 1Q 2025).New Risk • Feb 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Vietnamese stocks, typically moving 7.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.7% average weekly change). Earnings have declined by 12% per year over the past 5 years. Market cap is less than US$10m (₫134.9b market cap, or US$5.13m). Minor Risk Dividend is not well covered by earnings (131% payout ratio).Reported Earnings • Jan 26Full year 2025 earnings released: EPS: ₫382 (vs ₫335 in FY 2024)Full year 2025 results: EPS: ₫382 (up from ₫335 in FY 2024). Revenue: ₫254.0b (down 15% from FY 2024). Net income: ₫5.26b (up 14% from FY 2024). Profit margin: 2.1% (up from 1.6% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.New Risk • Dec 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Vietnamese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.1% per year over the past 5 years. Market cap is less than US$10m (₫146.7b market cap, or US$5.57m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.2% average weekly change).Upcoming Dividend • Nov 25Upcoming dividend of ₫500 per shareEligible shareholders must have bought the stock before 02 December 2025. Payment date: 17 December 2025. Trailing yield: 9.4%. Within top quartile of Vietnamese dividend payers (7.5%). Higher than average of industry peers (5.1%).Declared Dividend • Nov 08Dividend of ₫500 announcedShareholders will receive a dividend of ₫500. Ex-date: 2nd December 2025 Payment date: 17th December 2025 Dividend yield will be 4.9%, which is higher than the industry average of 3.7%. Sustainability & Growth The dividend has decreased over the past 96 years, indicating a lack of growth and stability in payments.Reported Earnings • Oct 25Third quarter 2025 earnings released: EPS: ₫368 (vs ₫89.00 in 3Q 2024)Third quarter 2025 results: EPS: ₫368 (up from ₫89.00 in 3Q 2024). Revenue: ₫57.7b (down 22% from 3Q 2024). Net income: ₫5.07b (up 314% from 3Q 2024). Profit margin: 8.8% (up from 1.7% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 25First quarter 2025 earnings released: EPS: ₫229 (vs ₫27.00 in 1Q 2024)First quarter 2025 results: EPS: ₫229 (up from ₫27.00 in 1Q 2024). Revenue: ₫82.5b (up 4.6% from 1Q 2024). Net income: ₫3.15b (up ₫2.77b from 1Q 2024). Profit margin: 3.8% (up from 0.5% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.New Risk • Jan 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Vietnamese stocks, typically moving 7.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Share price has been highly volatile over the past 3 months (7.3% average weekly change). Revenue has declined by 26% over the past year. Market cap is less than US$10m (₫172.8b market cap, or US$6.74m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Upcoming Dividend • Nov 29Upcoming dividend of ₫500 per shareEligible shareholders must have bought the stock before 06 December 2024. Payment date: 18 December 2024. Trailing yield: 9.1%. Within top quartile of Vietnamese dividend payers (8.2%). Higher than average of industry peers (4.4%).お知らせ • Nov 13SPM Corporation Announces Cash Dividend for the Year, Payable on December 18, 2024On November 12, 2024, SPM Corporation announced the record date to pay the 2024 cash dividend payment as follows: Record date: December 09, 2024. Exercise ratio: 5%/share (500 dongs/share). Payment date: December 18, 2024.New Risk • Oct 20New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended September 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Share price has been highly volatile over the past 3 months (7.5% average weekly change). Revenue has declined by 26% over the past year. Market cap is less than US$10m (₫155.6b market cap, or US$6.22m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.New Risk • Sep 30New major risk - Revenue and earnings growthRevenue has declined by 26% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 26% over the past year. Market cap is less than US$10m (₫157.0b market cap, or US$6.44m). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.1% average weekly change).New Risk • May 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Vietnamese stocks, typically moving 7.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.3% average weekly change). Market cap is less than US$10m (₫170.1b market cap, or US$6.63m). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.お知らせ • May 12SPM Corporation, Annual General Meeting, Jun 28, 2024SPM Corporation, Annual General Meeting, Jun 28, 2024. Location: c4, buu long street, ward 15, district 10, hcm VietnamNew Risk • May 07New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₫161.1b market cap, or US$6.28m). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.9% average weekly change).New Risk • Apr 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Vietnamese stocks, typically moving 6.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (6.7% average weekly change). Market cap is less than US$10m (₫154.2b market cap, or US$6.17m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Valuation Update With 7 Day Price Move • Oct 30Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₫11,300, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 13x in the Pharmaceuticals industry in Vietnam. Total loss to shareholders of 6.5% over the past three years.Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: ₫270 (vs ₫262 in 3Q 2022)Third quarter 2023 results: EPS: ₫270 (up from ₫262 in 3Q 2022). Revenue: ₫102.1b (down 42% from 3Q 2022). Net income: ₫3.71b (up 3.1% from 3Q 2022). Profit margin: 3.6% (up from 2.0% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.New Risk • Oct 26New major risk - Revenue and earnings growthRevenue has declined by 1.4% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 1.4% over the past year. Market cap is less than US$10m (₫188.6b market cap, or US$7.68m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.New Risk • Aug 04New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₫179.0b market cap, or US$7.54m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.お知らせ • May 13SPM Corporation, Annual General Meeting, Jun 28, 2023SPM Corporation, Annual General Meeting, Jun 28, 2023. Location: C4 Buu Long, ward 15, district 10, Ho Chi Minh city VietnamReported Earnings • Feb 03Full year 2022 earnings released: EPS: ₫1,788 (vs ₫1,466 in FY 2021)Full year 2022 results: EPS: ₫1,788 (up from ₫1,466 in FY 2021). Revenue: ₫699.6b (down 1.4% from FY 2021). Net income: ₫24.6b (up 22% from FY 2021). Profit margin: 3.5% (up from 2.8% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Nov 30Upcoming dividend of ₫500 per shareEligible shareholders must have bought the stock before 07 December 2022. Payment date: 19 December 2022. Trailing yield: 6.9%. Lower than top quartile of Vietnamese dividend payers (9.3%). Higher than average of industry peers (4.0%).お知らせ • Nov 21SPM Corporation Announces First Cash Dividend Payment for 2021, Payable on December 19, 2022SPM Corporation announced first cash dividend payment of 500 dongs per share for 2021. Payment date is December 19, 2022. Record date is December 8, 2022. Ex-right date is December 7, 2022.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Member of Supervisory Board Duong Huy was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Oct 23Third quarter 2021 earnings released: EPS: ₫186 (vs ₫50.00 in 3Q 2020)Third quarter 2021 results: EPS: ₫186 (up from ₫50.00 in 3Q 2020). Revenue: ₫139.6b (down 10% from 3Q 2020). Net income: ₫2.56b (up 276% from 3Q 2020). Profit margin: 1.8% (up from 0.4% in 3Q 2020). The increase in margin was driven by lower expenses.お知らせ • Sep 10SPM Corporation Announces CEO ChangesS.P.M Corporation received the resignation letter from Mr. Nguyen The Ky as CEO as from September 15, 2022 and the appointment of Mr. Nguyen The Quyen as right CEO as from September 15, 2022.Upcoming Dividend • Jul 12Upcoming dividend of ₫500 per shareEligible shareholders must have bought the stock before 19 July 2022. Payment date: 29 July 2022. The company last paid an ordinary dividend in February 2017. The average dividend yield among industry peers is 3.8%.お知らせ • Jul 01SPM Corporation Announces First Cash Dividend Payment for 2021, Payable on July 29, 2022SPM Corporation announced first cash dividend payment of 500 dongs per share for 2021. Payment date is July 29, 2022. Record date is July 20, 2022.お知らせ • May 12SPM Corporation, Annual General Meeting, Jun 28, 2022SPM Corporation, Annual General Meeting, Jun 28, 2022. Location: C4 Buu Long, ward 15, district 10 Ho Chi Minh VietnamBoard Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Member of Supervisory Board Duong Huy was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Mar 03Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₫22,350, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 16x in the Pharmaceuticals industry in Vietnam. Total returns to shareholders of 71% over the past three years.Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₫24,400, the stock trades at a trailing P/E ratio of 24.2x. Average trailing P/E is 17x in the Pharmaceuticals industry in Vietnam. Total returns to shareholders of 88% over the past three years.Valuation Update With 7 Day Price Move • Sep 21Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₫22,300, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 16x in the Pharmaceuticals industry in Vietnam. Total returns to shareholders of 73% over the past three years.Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₫16,550, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 16x in the Pharmaceuticals industry in Vietnam. Total returns to shareholders of 38% over the past three years.Reported Earnings • Jul 23Second quarter 2021 earnings released: EPS ₫477 (vs ₫168 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₫174.0b (up 52% from 2Q 2020). Net income: ₫6.56b (up 184% from 2Q 2020). Profit margin: 3.8% (up from 2.0% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has remained flat.Is New 90 Day High Low • Jan 06New 90-day high: ₫13,950The company is up 13% from its price of ₫12,400 on 06 October 2020. The Vietnamese market is up 21% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Pharmaceuticals industry, which is up 7.0% over the same period.Is New 90 Day High Low • Nov 24New 90-day low: ₫12,000The company is down 7.0% from its price of ₫12,950 on 25 August 2020. The Vietnamese market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 1.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、SPM は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測HOSE:SPM - アナリストの将来予測と過去の財務データ ( )VND Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/2026217,448-1,62949,95161,059N/A12/31/2025253,956-1,69749,90462,003N/A9/30/2025278,99016,76335,12548,873N/A6/30/2025295,00312,91838,17546,065N/A3/31/2025301,4266,50523,95629,974N/A12/31/2024297,7754,61853,01258,469N/A9/30/2024303,483-1,64922,66929,883N/A12/31/2023406,10512,11728,08343,801N/A9/30/2023529,84418,98047,10462,480N/A12/31/2022699,63324,62327,77145,234N/A9/30/2022713,05524,42922,36539,223N/A3/31/2022677,87723,113-5,5074,567N/A12/31/2021709,89020,1834,28213,476N/A9/30/2021689,11715,74224,86752,572N/A6/30/2021705,33013,86118,90447,107N/A3/31/2021675,6578,048-7,59121,368N/A12/31/2020609,9948,187-1,28227,365N/A9/30/2020552,7128,180-38,583-25,751N/A3/31/2020487,3469,224-41,307-25,814N/A12/31/2019492,4769,086N/A-34,796N/A6/30/2018380,02011,855N/A-6,523N/A3/31/2018411,01510,542N/A-58,951N/A12/31/2017636,02315,741N/A-48,776N/A9/30/2017668,412360N/A-24,518N/A6/30/2017673,648247N/A-10,706N/A3/31/2017649,3287,787N/A60,576N/A12/31/2016460,7567,886N/A44,421N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: SPMの予測収益成長が 貯蓄率 ( 3.2% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: SPMの収益がVN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: SPMの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: SPMの収益がVN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: SPMの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: SPMの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/31 23:36終値2026/05/29 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋SPM Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 06SPM Corporation, Annual General Meeting, Jun 26, 2026SPM Corporation, Annual General Meeting, Jun 26, 2026.
Reported Earnings • Apr 25First quarter 2026 earnings released: EPS: ₫234 (vs ₫229 in 1Q 2025)First quarter 2026 results: EPS: ₫234 (up from ₫229 in 1Q 2025). Revenue: ₫46.0b (down 44% from 1Q 2025). Net income: ₫3.22b (up 2.1% from 1Q 2025). Profit margin: 7.0% (up from 3.8% in 1Q 2025).
New Risk • Feb 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Vietnamese stocks, typically moving 7.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.7% average weekly change). Earnings have declined by 12% per year over the past 5 years. Market cap is less than US$10m (₫134.9b market cap, or US$5.13m). Minor Risk Dividend is not well covered by earnings (131% payout ratio).
Reported Earnings • Jan 26Full year 2025 earnings released: EPS: ₫382 (vs ₫335 in FY 2024)Full year 2025 results: EPS: ₫382 (up from ₫335 in FY 2024). Revenue: ₫254.0b (down 15% from FY 2024). Net income: ₫5.26b (up 14% from FY 2024). Profit margin: 2.1% (up from 1.6% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
New Risk • Dec 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Vietnamese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.1% per year over the past 5 years. Market cap is less than US$10m (₫146.7b market cap, or US$5.57m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.2% average weekly change).
Upcoming Dividend • Nov 25Upcoming dividend of ₫500 per shareEligible shareholders must have bought the stock before 02 December 2025. Payment date: 17 December 2025. Trailing yield: 9.4%. Within top quartile of Vietnamese dividend payers (7.5%). Higher than average of industry peers (5.1%).
Declared Dividend • Nov 08Dividend of ₫500 announcedShareholders will receive a dividend of ₫500. Ex-date: 2nd December 2025 Payment date: 17th December 2025 Dividend yield will be 4.9%, which is higher than the industry average of 3.7%. Sustainability & Growth The dividend has decreased over the past 96 years, indicating a lack of growth and stability in payments.
Reported Earnings • Oct 25Third quarter 2025 earnings released: EPS: ₫368 (vs ₫89.00 in 3Q 2024)Third quarter 2025 results: EPS: ₫368 (up from ₫89.00 in 3Q 2024). Revenue: ₫57.7b (down 22% from 3Q 2024). Net income: ₫5.07b (up 314% from 3Q 2024). Profit margin: 8.8% (up from 1.7% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 25First quarter 2025 earnings released: EPS: ₫229 (vs ₫27.00 in 1Q 2024)First quarter 2025 results: EPS: ₫229 (up from ₫27.00 in 1Q 2024). Revenue: ₫82.5b (up 4.6% from 1Q 2024). Net income: ₫3.15b (up ₫2.77b from 1Q 2024). Profit margin: 3.8% (up from 0.5% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
New Risk • Jan 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Vietnamese stocks, typically moving 7.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Share price has been highly volatile over the past 3 months (7.3% average weekly change). Revenue has declined by 26% over the past year. Market cap is less than US$10m (₫172.8b market cap, or US$6.74m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Upcoming Dividend • Nov 29Upcoming dividend of ₫500 per shareEligible shareholders must have bought the stock before 06 December 2024. Payment date: 18 December 2024. Trailing yield: 9.1%. Within top quartile of Vietnamese dividend payers (8.2%). Higher than average of industry peers (4.4%).
お知らせ • Nov 13SPM Corporation Announces Cash Dividend for the Year, Payable on December 18, 2024On November 12, 2024, SPM Corporation announced the record date to pay the 2024 cash dividend payment as follows: Record date: December 09, 2024. Exercise ratio: 5%/share (500 dongs/share). Payment date: December 18, 2024.
New Risk • Oct 20New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended September 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2023 fiscal period end). Share price has been highly volatile over the past 3 months (7.5% average weekly change). Revenue has declined by 26% over the past year. Market cap is less than US$10m (₫155.6b market cap, or US$6.22m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
New Risk • Sep 30New major risk - Revenue and earnings growthRevenue has declined by 26% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 26% over the past year. Market cap is less than US$10m (₫157.0b market cap, or US$6.44m). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.1% average weekly change).
New Risk • May 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Vietnamese stocks, typically moving 7.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.3% average weekly change). Market cap is less than US$10m (₫170.1b market cap, or US$6.63m). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
お知らせ • May 12SPM Corporation, Annual General Meeting, Jun 28, 2024SPM Corporation, Annual General Meeting, Jun 28, 2024. Location: c4, buu long street, ward 15, district 10, hcm Vietnam
New Risk • May 07New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₫161.1b market cap, or US$6.28m). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.9% average weekly change).
New Risk • Apr 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Vietnamese stocks, typically moving 6.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (6.7% average weekly change). Market cap is less than US$10m (₫154.2b market cap, or US$6.17m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Valuation Update With 7 Day Price Move • Oct 30Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₫11,300, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 13x in the Pharmaceuticals industry in Vietnam. Total loss to shareholders of 6.5% over the past three years.
Reported Earnings • Oct 26Third quarter 2023 earnings released: EPS: ₫270 (vs ₫262 in 3Q 2022)Third quarter 2023 results: EPS: ₫270 (up from ₫262 in 3Q 2022). Revenue: ₫102.1b (down 42% from 3Q 2022). Net income: ₫3.71b (up 3.1% from 3Q 2022). Profit margin: 3.6% (up from 2.0% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
New Risk • Oct 26New major risk - Revenue and earnings growthRevenue has declined by 1.4% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 1.4% over the past year. Market cap is less than US$10m (₫188.6b market cap, or US$7.68m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
New Risk • Aug 04New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₫179.0b market cap, or US$7.54m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
お知らせ • May 13SPM Corporation, Annual General Meeting, Jun 28, 2023SPM Corporation, Annual General Meeting, Jun 28, 2023. Location: C4 Buu Long, ward 15, district 10, Ho Chi Minh city Vietnam
Reported Earnings • Feb 03Full year 2022 earnings released: EPS: ₫1,788 (vs ₫1,466 in FY 2021)Full year 2022 results: EPS: ₫1,788 (up from ₫1,466 in FY 2021). Revenue: ₫699.6b (down 1.4% from FY 2021). Net income: ₫24.6b (up 22% from FY 2021). Profit margin: 3.5% (up from 2.8% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Nov 30Upcoming dividend of ₫500 per shareEligible shareholders must have bought the stock before 07 December 2022. Payment date: 19 December 2022. Trailing yield: 6.9%. Lower than top quartile of Vietnamese dividend payers (9.3%). Higher than average of industry peers (4.0%).
お知らせ • Nov 21SPM Corporation Announces First Cash Dividend Payment for 2021, Payable on December 19, 2022SPM Corporation announced first cash dividend payment of 500 dongs per share for 2021. Payment date is December 19, 2022. Record date is December 8, 2022. Ex-right date is December 7, 2022.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Member of Supervisory Board Duong Huy was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 23Third quarter 2021 earnings released: EPS: ₫186 (vs ₫50.00 in 3Q 2020)Third quarter 2021 results: EPS: ₫186 (up from ₫50.00 in 3Q 2020). Revenue: ₫139.6b (down 10% from 3Q 2020). Net income: ₫2.56b (up 276% from 3Q 2020). Profit margin: 1.8% (up from 0.4% in 3Q 2020). The increase in margin was driven by lower expenses.
お知らせ • Sep 10SPM Corporation Announces CEO ChangesS.P.M Corporation received the resignation letter from Mr. Nguyen The Ky as CEO as from September 15, 2022 and the appointment of Mr. Nguyen The Quyen as right CEO as from September 15, 2022.
Upcoming Dividend • Jul 12Upcoming dividend of ₫500 per shareEligible shareholders must have bought the stock before 19 July 2022. Payment date: 29 July 2022. The company last paid an ordinary dividend in February 2017. The average dividend yield among industry peers is 3.8%.
お知らせ • Jul 01SPM Corporation Announces First Cash Dividend Payment for 2021, Payable on July 29, 2022SPM Corporation announced first cash dividend payment of 500 dongs per share for 2021. Payment date is July 29, 2022. Record date is July 20, 2022.
お知らせ • May 12SPM Corporation, Annual General Meeting, Jun 28, 2022SPM Corporation, Annual General Meeting, Jun 28, 2022. Location: C4 Buu Long, ward 15, district 10 Ho Chi Minh Vietnam
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Member of Supervisory Board Duong Huy was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Mar 03Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₫22,350, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 16x in the Pharmaceuticals industry in Vietnam. Total returns to shareholders of 71% over the past three years.
Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₫24,400, the stock trades at a trailing P/E ratio of 24.2x. Average trailing P/E is 17x in the Pharmaceuticals industry in Vietnam. Total returns to shareholders of 88% over the past three years.
Valuation Update With 7 Day Price Move • Sep 21Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₫22,300, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 16x in the Pharmaceuticals industry in Vietnam. Total returns to shareholders of 73% over the past three years.
Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₫16,550, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 16x in the Pharmaceuticals industry in Vietnam. Total returns to shareholders of 38% over the past three years.
Reported Earnings • Jul 23Second quarter 2021 earnings released: EPS ₫477 (vs ₫168 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₫174.0b (up 52% from 2Q 2020). Net income: ₫6.56b (up 184% from 2Q 2020). Profit margin: 3.8% (up from 2.0% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has remained flat.
Is New 90 Day High Low • Jan 06New 90-day high: ₫13,950The company is up 13% from its price of ₫12,400 on 06 October 2020. The Vietnamese market is up 21% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Pharmaceuticals industry, which is up 7.0% over the same period.
Is New 90 Day High Low • Nov 24New 90-day low: ₫12,000The company is down 7.0% from its price of ₫12,950 on 25 August 2020. The Vietnamese market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 1.0% over the same period.